Infectious Diseases (except HIV/AIDS)

  1. Viral cultures, Polymerase Chain Reaction Cycle Threshold Values and Viral Load Estimation for SARS-CoV-2 Infectious Potential Assessment in Hematopoietic Stem Cell and Solid Organ Transplant Patients: A Systematic Review

    1. Tom Jefferson
    2. Elizabeth A. Spencer
    3. John M. Conly
    4. Elena C. Rosca
    5. Susanna Maltoni
    6. Jon Brassey
    7. Igho J. Onakpoya
    8. David H. Evans
    9. Carl J. Heneghan
    10. Annette Plüddemann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2

    1. Apurv Soni
    2. Carly Herbert
    3. Andreas Filippaios
    4. John Broach
    5. Andres Colubri
    6. Nisha Fahey
    7. Kelsey Woods
    8. Janvi Nanavati
    9. Colton Wright
    10. Taylor Orwig
    11. Karen Gilliam
    12. Vik Kheterpal
    13. Thejas Suvarna
    14. Chris Nowak
    15. Summer Schrader
    16. Honghuang Lin
    17. Laurel O’Connor
    18. Caitlin Pretz
    19. Didem Ayturk
    20. Elizabeth Orvek
    21. Julie Flahive
    22. Peter Lazar
    23. Qiming Shi
    24. Chad Achenbach
    25. Robert Murphy
    26. Matthew Robinson
    27. Laura Gibson
    28. Pamela Stamegna
    29. Nathaniel Hafer
    30. Katherine Luzuriaga
    31. Bruce Barton
    32. William Heetderks
    33. Yukari C. Manabe
    34. David McManus

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Assessment of potential risk factors for COVID-19 among health care workers in a health care setting in Delhi, India -a cohort study

    1. Mridu Dudeja
    2. Aqsa Shaikh
    3. Farzana Islam
    4. Yasir Alvi
    5. Mohammad Ahmad
    6. Varun Kashyap
    7. Vishal Singh
    8. Anisur Rahman
    9. Meely Panda
    10. Neetu Shree
    11. Shyamasree Nandy
    12. Vineet Jain

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901

    1. Josue Antonio Estrada
    2. Chien-Yu Cheng
    3. Shin-Yen Ku
    4. Hui-Chun Hu
    5. Hsiu-Wen Yeh
    6. Yi-Chun Lin
    7. Cheng-Pin Chen
    8. Shu-Hsing Cheng
    9. Robert Janssen
    10. I-Feng Lin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

    1. Jennifer Pillay
    2. Lindsay Gaudet
    3. Aireen Wingert
    4. Liza Bialy
    5. Andrew S Mackie
    6. D Ian Paterson
    7. Lisa Hartling

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  6. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial

    1. Pengfei Jin
    2. Xiling Guo
    3. Wei Chen
    4. Shihua Ma
    5. Hongxing Pan
    6. Lianpan Dai
    7. Pan Du
    8. Lili Wang
    9. Lairun Jin
    10. Yin Chen
    11. Fengjuan Shi
    12. Jingxian Liu
    13. Xiaoyu Xu
    14. Yanan Zhang
    15. George F. Gao
    16. Cancan Chen
    17. Jialu Feng
    18. Jingxin Li
    19. Fengcai Zhu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data

    1. Shannon L. Reynolds
    2. Harvey W. Kaufman
    3. William A. Meyer
    4. Chris Bush
    5. Oren Cohen
    6. Kathy Cronin
    7. Carly Kabelac
    8. Sandy Leonard
    9. Steve Anderson
    10. Valentina Petkov
    11. Douglas Lowy
    12. Norman Sharpless
    13. Lynne Penberthy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination

    1. Yukiya Kurahashi
    2. Koichi Furukawa
    3. Silvia Sutandhio
    4. Lidya Handayani Tjan
    5. Sachiyo Iwata
    6. Shigeru Sano
    7. Yoshiki Tohma
    8. Hiroyuki Ohkita
    9. Sachiko Nakamura
    10. Mitsuhiro Nishimura
    11. Jun Arii
    12. Tatsunori Kiriu
    13. Masatsugu Yamamoto
    14. Tatsuya Nagano
    15. Yoshihiro Nishimura
    16. Yasuko Mori

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Clinical and virologic factors associated with outcomes of COVID‐19 before and after vaccination among Veterans: Retrospective analysis from six New England states

    1. Megan Lee
    2. Danielle Cosentino
    3. Tassos C. Kyriakides
    4. Tricia Cavallaro
    5. Gary Stack
    6. Shaili Gupta

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Booster protection against Omicron infection in a highly vaccinated cohort

    1. Caroline G. Tai
    2. Lisa L. Maragakis
    3. Sarah Connolly
    4. John DiFiori
    5. Leroy Sims
    6. Eleanor Adams
    7. Deverick J. Anderson
    8. Michael H. Merson
    9. David D. Ho
    10. Yonatan Grad
    11. Christina DeFilippo Mack

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 193 of 716 Next